November 4, 2024
TOPLINE: Long-term residential exposure to fine particulate matter, nitrogen dioxide, and black carbon are positively linked to lung cancer incidence and mortality, with similar risks found […]
November 4, 2024
TOPLINE: Patients with cancer who participated in the Medicare Low-Income Subsidy program were less likely to receive any systemic cancer therapy compared with patients not participating […]
November 1, 2024
A growing body of research suggests that clinicians can offer chimeric antigen receptor (CAR) T-cell therapy safely and effectively on an outpatient basis — a positive […]
October 31, 2024
In late October, a federal grand jury charged a Detroit-area medical oncologist Naveed Aslam, MD, in an indictment for his part in a scheme to illegally […]
October 31, 2024
TOPLINE: Patients with rectal cancer managed by watch and wait and subsequent local regrowth have a higher risk for distant metastases than those undergoing immediate surgery. […]
October 31, 2024
TOPLINE: Fidanacogene elaparvovec gene therapy reduced the annualized bleeding rate by 71% in patients with hemophilia B. Factor IX activity levels were sustained at 26.9% at […]
October 31, 2024
TOPLINE: Trastuzumab duocarmazine (T-Duo) improved progression-free survival to 7.0 months compared with 4.9 months with a physician’s choice in advanced human epidermal growth factor receptor 2–positive […]
October 30, 2024
TOPLINE: Combining thoracic radiotherapy with first-line EGFR tyrosine kinase inhibitor (TKI) therapy improves progression-free survival by 6.5 months and overall survival by more than 8 months […]
October 29, 2024
Last April, the US Preventive Services Task Force (USPSTF) revised their breast cancer screening guidelines to recommend average-risk women start their screening mammograms at age 40, […]